Ryoji Tamura
Hamamatsu University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Ryoji Tamura.
Respirology | 2002
Hiroshi Hayakawa; Masahiro Shirai; Atsuhiko Sato; Yasuyuki Yoshizawa; Akihito Todate; Shiro Imokawa; Takafumi Suda; Kingo Chida; Ryoji Tamura; Kyousuke Ishihara; Shigeki Saiki; Masayuki Ando
Objective: Only limited information exists concerning the clinical and pathological features of chronic hypersensitivity pneumonitis (HP) in Japan and elsewhere. We present data on clinicopathological features of chronic HP obtained through a Japanese nationwide survey.
Current Therapeutic Research-clinical and Experimental | 1994
Hideki Suganuma; Atsuhiko Sato; Ryoji Tamura; Kingo Chida
Abstract Since interferon-alfa (IFN-α) and Sho-saiko-to (SST) are known to modulate immune responses, their immunological effects may be responsible for the induction of interstitial pneumonia. Additionally, fibroblasts play an important role in lung fibrosis. Therefore, the in vitro effects of IFN-α and/or SST on cytokine production of fibroblasts were examined. No difference in cytokine production was shown among natural IFN-α, IFN-α-2a, and IFN-α-2b. Fibroblasts from three control subjects and four patients with idiopathic pulmonary fibrosis (IPF) were used. Cells from the control and IPF groups produced interleukin-6 (IL-6) dose-dependently with either IFN-α or SST treatment. Combined administration of these agents produced greater IL-6 production. In all controls, interleukin-8 (IL-8) production by fibroblasts was increased with SST but suppressed with IFN-α. In contrast, in 2 of 4 IPF patients, IL-8 production was increased with IFN-α. More importantly, there was a greater production of IL-8 when stimulated with both IFN-α and SST in the IPF group. Proliferation of control and IPF fibroblasts was inhibited equally by each drug. These results suggest that fibroblast cytokine production, augmented by IFN-α and/or SST, may play a role in the development or exacerbation of interstitial pneumonia.
The Journal of Rheumatology | 2005
Tomoyuki Fujisawa; Takafumi Suda; Yutaro Nakamura; Noriyuki Enomoto; Kyotaro Ide; Mikio Toyoshima; Hiroshi Uchiyama; Ryoji Tamura; Masaaki Ida; Takeshi Yagi; Kazumasa Yasuda; Hitoshi Genma; Hiroshi Hayakawa; Kingo Chida; Hirotoshi Nakamura
Sarcoidosis Vasculitis and Diffuse Lung Diseases | 2003
Yutaro Nakamura; Kingo Chida; Takafumi Suda; Hiroshi Hayakawa; Masatoshi Iwata; Shiro Imokawa; Tomoyoshi Tsuchiya; Masaaki Ida; Hitoshi Gemma; Kazumasa Yasuda; Takeshi Yagi; Toshihiro Shirai; Ryoji Tamura; Yutaka Nakano; Takeo Hirata; Hirotoshi Nakamura; Thomas V. Colby
Internal Medicine | 1994
Shiro Imokawa; Atsuhiko Sato; Mikio Toyoshima; Atsushi Yoshitomi; Ryoji Tamura; Takafumi Suda; Hideki Suganuma; Takeshi Yagi; Masatoshi Iwata; Hiroshi Hayakawa; Kingo Chida
Internal Medicine | 1994
Takafumi Suda; Atsuhiko Sato; Mikio Toyoshima; Shiro Imokawa; Atsushi Yoshitomi; Ryoji Tamura; Hideki Suganuma; Takeshi Yagi; Hiroshi Hayakawa; Masahiro Shirai; Kingo Chida
Archive | 1995
Hideki Suganuma; Atsuhiko Sato; Ryoji Tamura